
CDC SARS Response Timeline | About | CDC - Centers for Disease …
December 31: Globally, WHO received reports of SARS from 29 countries and regions; 8,096 persons with probable SARS resulting in 774 deaths. In the United States, eight SARS infections were documented by laboratory testing and an additional …
SARS | 2004 Media News and Alerts Archive | CDC
SARS, CDC Alerts, News, and Notices on Severe Acute Respiratory Syndrome information
Remembering SARS – 10 Years Later | About | CDC - Centers for …
In the 2003 global disease outbreak, what became known as SARS-CoV started as a mystery illness—without name, origin, or cure. Public health scientists across the globe scrambled to understand and contain this health threat.
COVID-19 Wastewater Data – Current Levels | NWSS | CDC
Mar 7, 2025 · This interactive map shows the current wastewater viral activity level of SARS-CoV-2 (the virus that causes COVID-19) for each state or territory. Wastewater data are updated every Friday with the previous week’s data, which allows for data to be reviewed for accuracy.
Public Health Interventions and SARS Spread, 2003
May 4, 2011 · In the case of SARS, interventions at a country’s borders should not detract from efforts to identify and isolate infected persons within the country, monitor or quarantine their contacts, and strengthen infection control in healthcare settings.
CDC Tracks New SARS-CoV-2 Variant, BA.2.87.1 | NCIRD | CDC
Feb 9, 2024 · BA.2.87.1, a new variant of SARS-CoV-2, the virus that causes COVID-19, was identified in South Africa by the National Institute for Communicable Diseases. CDC is closely tracking this variant because of the large number of mutations when compared to …
Coronavirus Disease 2019 (COVID-19) | COVID-19 | CDC
COVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2. It can be very contagious and spreads quickly. View All
Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and …
We assayed SARS-CoV-2 spike protein receptor-binding domain and neutralizing antibody titers for a convenience sample of residual clinical serum specimens that had evidence of prior SARS-CoV-2 infection gathered during January 2021–February 2022.
CDC’s Influenza SARS-CoV-2 Multiplex Assay
Dec 3, 2024 · The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcription polymerase chain reaction (rRT-PCR) laboratory test that can simultaneously detect and differentiate between influenza A, influenza B, and SARS-CoV-2 …
Fear and Stigma: The Epidemic within the SARS Outbreak
Jan 27, 2011 · In creating a rapid public health intervention to mitigate behaviors and practices associated with SARS-related fear, the team recognized the need to address the experiences of persons at greatest risk for experiencing SARS-related fear, stigma, and discrimination.
- Some results have been removed